Loading

JSM Clinical Case Reports

Tuberous Xanthomatosis as a Presentation of Familial Hypercholesterolemia

Case Report | Open Access | Volume 4 | Issue 5

  • 1. General Surgery Resident, Hospital de especialidades Centro médico nacional La raza, México
  • 2. Family physician, Hospital General Regional 29, México
  • 3. General Surgeon, Hospital de especialidades Centro médico nacional La raza, México
+ Show More - Show Less
Corresponding Authors
Edgar Vargas-Flores, General Surgery Resident, Hospital de especialidades Centro médico nacional La raza, Calle Enrico Carusso 125, Torre A Int. 9, Colonia Peralvillo, Delegación Cuauhtémoc. C.P. 05220, Distrito Federal, México, Tel: 52-55-5499-5292
Abstract

Xanthomas are localized lipid deposits within organs that may manifest as papules, plaques, or nodules in skin. The subtype of xanthoma provides a clue to the underlying lipid abnormality. Accurate diagnosis of xanthomas is important because it can lead to the identification and treatment of underlying disease. Xanthomas associated with familial hypercholesterolemia are an exception. In patients with this disorder they often begin to develop prior to the age of 10 years. Herein, we report a case of a 10-years-old who presented with a 2-year history of slow and multiple mass growths on the extensor surfaces of the upper and lower extremities laboratory findings advocated familial hypercholesterolemia. These lesions were surgically removed for cosmetic reasons. Clinicians should be aware of differential diagnosis when approaching cutaneous lesions related to lipid disorders.

Citation

Vargas-Flores E, Lourdes Estrada-Alpizar E, Arenas-Osuna J (2016) Tuberous Xanthomatosis as a Presentation of Familial Hypercholesterolemia. JSM Clin Case Rep 4(5): 1114

Keywords

Xanthomatosis; Familial hypercholesterolemia; Xanthomas; Lipid disorders

ABBREVIATION

LP: Lipoprotein; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; VLDL: Very Low Density Lipoprotein; IDL: Intermediate Density Lipoprotein; ErYAG: Erbium-Doped Yttrium Aluminium Garnet; DM: Diabetes Mellitus; Apo: Apoprotein

INTRODUCTION

Xanthomas are localized lipid deposits within organs that may manifest as papules, plaques, or nodules in skin. The clinical variants of cutaneous xanthomas include a wide arrange of lesions such as cutaneous xanthomas that can be idiopathic or may present as a sign of an inherited abnormality of lipoprotein metabolism (primary dyslipidemia), hyperlipidemia secondary to systemic disease or medication, or hematologic disease. The subtype of xanthoma provides a clue to the underlying abnormality. Accurate diagnosis of xanthomas is important because it can lead to the identification and treatment of underlying disease. Epidemiologic data on cutaneous xanthomas are limited. Tuberous, tuberoeruptive, tendinous, and nonxanthelasma plane xanthomas typically occur in association with inherited or acquired dyslipidemia or hematologic disease [1,2]. Cutaneous xanthomas most often present in adulthood. Xanthomas associated with familial hypercholesterolemia are an exception. In patients with this disorder they often begin to develop prior to the age of 10 years and tend to occur in both males and females and do not appear to be a clear sex predilection. The pathogenic mechanism that leads to cutaneous xanthomas are not fully understood and may differ based upon the etiology and type of xanthoma. For xanthomas occurring in association with hyperlipidemia, it is hypothesized that when serum levels of lipoproteins are substantially elevated, extravasations of lipoproteins through dermal capillary blood vessels with subsequent engulfment by macrophages leads to the lipid-laden cells found in xanthomas [3,4]. Primary or secondary hyperlipidemic states can lead to xanthoma formation. Primary hyperlipidemia results from genetic defects in receptors, receptor ligands, or enzymes involved in lipid metabolism. Causes of secondary hyperlipidemia include underlying disease states and medications. Examples of diseases and physiologic states associated with hyperlipidemia include obesity, diabetes mellitus, hypothyroidism, nephrotic syndrome, cholestasis, and pregnancy [5-10]. Examples of medications that may lead to hyperlipidemia (often hypertriglyceridemia) include estrogens, tamoxifen, prednisone, oral retinoids, cyclosporine, olanzapine, and protease inhibitors [11-14].

Immune complex formation between antibodies and lipoproteins leading to lipid accumulation within macrophages is a proposed mechanism for xanthoma formation in the setting of monoclonal gammopathy [15]. The clinical variants of cutaneous xanthoma include eruptive, tuberous, tuberoeruptive, tendinous, plane (including xanthelasma), and verruciform xanthomas. Most xanthomas present as erythematous to yellow papules, plaques or nodules representative of lipid deposition in the skin. The characteristic histologic feature of cutaneous xanthomas is lipid-laden macrophages, also known as “foam cells.” The number of foam cells and the presence of associated findings, such as inflammatory cells, extracellular lipid deposition, and fibrosis vary with the type and age of the xanthoma. Eruptive xanthomas often have prominent extracellular lipid deposition, and tuberous and tendinous xanthomas often have large foam cells with associated fibrosis [1,16]. Tuberous xanthomas are yelloworange or erythematous papules or nodules located over joints or extensor surfaces of the extremities, especially the elbows and knees and they may be solitary or grouped and they can reach sizes up to 3 cm and manly occur in hypercholesterolemic states, such as with familial hypercholesterolemia (elevated low-density lipoprotein levels) or when intermediate density lipoprotein levels are high (familial dysbetalipoproteinemia), in which case the serum cholesterol and triglyceride levels may be similarly increased (eg, each is approximately 400 mg/dL) [17].

CASE PRESENTATION

A 10-years-old boy presents as an outpatient in a rural hospital complaining of slow and multiple mass growth on extensor surface of right elbow and both knees since the age of 8 years old. He has no remarkable past medical history. On physical exam, the patient does not reveal any signs of distress, focused examination shows an arrange of small solitary masses of approximately 3x3 cm located at the extensor surfaces of right elbow (Figure 1), left and right knee.

Figure 1 Tuberous xanthoma on the extensor surface of the right elbow.

On palpation they present as a firm, mobile and non-painful nodules, smaller multiple lesions of approximately 5 mm were seen on the inferior and superior pole adjacent to the patellar region of the right and left knee respectively (Figure 2).

Laboratory studies revealed a high low-density lipoprotein level measured at 623 mg/dL, a 12 lead EKG was found to have no apparent cardiac abnormalities. With biochemical results and a typical clinical presentation of tuberous xanthomas, a diagnosis of familial hypercholesterolemia was established. The patient was offered initial medical treatment with high dose statins, ezetimibe and elective surgical resection of xanthomas which occurred without any complication with surgical findings of one firm yellowish nodule located at the extensor surface of right elbow of 3x3 cm, one firm yellowish round nodule of 3x3 located on the anterolateral surface of the patella and two firm nodules at the left and inferior borders of the left patella of 3x3 cm and 2x2 cm respectively without any compromise of surrounding structures. After his surgical intervention the patient underwent an uneventful recovery and it was discharged after 16 hours of in hospital surveillance.

DISCUSSION

The diagnosis of cutaneous xanthomas involves determining the type of xanthoma and the underlying cause through the patient history, physical examination, and relevant laboratory studies. Often, the classic yellow or yellow-red color and distribution of eruptive, tuberous, and plane xanthomas (eg, eyelids in xanthelasma) enables a presumptive diagnosis. Correlation of the clinical, biochemical and pathologic findings confirms the diagnosis. The patient history should include an assessment for risk factors for xanthoma development such as underlying diseases (eg, diabetes, thyroid disease, nephrotic syndrome, hematologic disease), medications that may cause hyperlipidemia (eg, estrogens, tamoxifen, prednisone, oral retinoids, cyclosporine, olanzapine, and protease inhibitors) , family history of primary lipid disorders or diseases associated with hyperlipidemia. The physical examination should include an assessment of the morphology and location of the xanthomas. Physical findings that suggest particular variants include eruptive xanthomas (Multiple small, yellow to yellow-red papules on the buttocks or extensor extremities), tuberous xanthomas (Yelloworange or erythematous papules or nodules on the extensor extremities or joints), tendinous xanthomas (skin-colored, mobile nodules over tendons or ligaments), plane xanthomas (yellow, thin plaques on the eyelids, neck, trunk, shoulders, or axillae (also known as xanthelasma), verruciform xanthomas (verrucous papules in the oral cavity or on anogenital skin) (Figure 3).

Figure 3 Tuberous, eruptive and tendinous xanthomas in both knees.

A fasting lipid panel to evaluate for dyslipidemia should be performed in all patients with xanthomas, with the exception of patients with verruciform xanthomas. Verruciform xanthomas are not associated with hyperlipidemia. Patients with tendinous or tuberous xanthomas automatically should be evaluated for an inherited dyslipidemia. In the absence of dyslipidemia, a diagnosis of eruptive, tuberous, or tendinous xanthomas should be reconsidered, given the strong association of these subtypes with dyslipidemia. Tendinous and tuberous xanthomas may resemble other nodular eruptions with predilections for sites over joints or tendons. Examples include rheumatoid nodules gouty tophi, subcutaneous granuloma annulare and erythema elevatumdiutinum. Knowledge of underlying medical conditions is useful for narrowing the differential diagnosis. Verrucous xanthomas on the oral and genital mucosa may be clinically confused with condylomata, oral papillomas, verrucous carcinoma, and squamous cell carcinoma. Cutaneous xanthomas are not lifethreatening and are usually asymptomatic. Therefore, treat specifically for cutaneous xanthomas is not mandatory, although it is often desired for cosmetic reasons. However, pharmacologic treatment of dyslipidemia is usually indicated and often leads to concomitant improvement in eruptive, tuberous, tendinous, and plane xanthomas caused by hyperlipidemia. Eruptive xanthomas typically resolve within several weeks when triglyceride levels are reduced. Tuberous and tendinous xanthomas are slower to regress during treatment of dyslipidemia. Different approaches are necessary for the treatment of xanthomas that are not associated with dyslipidemia. Normolipidemic patients with xanthelasma who desire treatment are primarily treated with surgical excision or destructive interventions. Traditionally, surgical excision has been used, with good cosmetic results [18]. Other effective treatment methods include destruction of xanthelasma with cryotherapy, 70 percent trichloroacetic acid chemical peels, and treatment with carbon dioxide or erbiumdoped yttrium aluminium garnet (ErYAG) lasers [19-23]. Without treatment, xanthomas typically persist. Patients with hyperlipidemia-associated xanthomas require clinical follow up for morbidities associated with hyperlipidemia and underlying causes of hyperlipidemia [Table 1].

Table 1: Major types of hyperlipidemia [23].

Table 1: Major types of hyperlipidemia [23].

Type

Laboratory findings

Clinical findings

Skin (types of xanthoma)

Systemic

Type I (Familial LP deficiency, familial hyperchylomicronemia)

Slow chylomicron clearance

Reduced LDL and HDL levels

Hypertriglyceridemia

Eruptive

No increased risk of coronary artery disease

Type II (Familial Hypercholesterolemia or Familial deficiency of apo B-100)

Reduced LDL clearance

Hypercholesterolemia

Tendinous, tuberoeruptive, tuberous, plane, (xanthelasma, intertriginous areas, interdigital web spaces)

Atherosclerosis of peripheral and coronary arteries

Type III (Familial dysbetalipoproteinemia, broad beta disease, apo E deficiency)

Elevated levels of chylomicron remnants and IDLs

Hypercholesterolemia

Hypertriglyceridemia

Tuberoeruptive, tuberous, plane and tendinous

Atherosclerosis of peripheral and coronary arteries

Type IV (Endogenous familial Hypertriglyceridemia)

Increased VLDLs

Hypertriglyceridemia

Eruptive

Frequently associated with type 2 DM, obesity and alcoholism

Type V

Decreased LDLs and HDLs

Hypertriglyceridemia

Eruptive

DM

Abbreviations: LP: Lipoprotein; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; VLDL: Very Low Density Lipoprotein; IDL: Intermediate Density Lipoprotein; ErYAG: Erbium-Doped Yttrium Aluminium Garnet; DM: Diabetes Mellitus; Apo: Apoprotein

In addition, patients with diffuse plane xanthomas who lack evidence for hematologic disease at the time of diagnosis require long-term follow up for the development of hematologic disease [17].

CONCLUSION

In conclusion, this case underscores the importance of proper identification of nodular lesions and a differential diagnosis of specific subtypes of xanthomas as a way to suspect dylipidemic disorders. Resection of the lesion is the treatment of choice usually for cosmetic reasons. The size and location of this dermatologic illness should always be considered in the diagnosis and surgical approach. In spite of adequate treatment, high recurrence should always be expected. Therefore, proper identification and management of the underlying disorder should be achieved.

ACKNOWLEDGEMENT

Special greetings to the department of general surgery of the Hospital de Especialidades. Centro MédicoNacional la raza in Mexico City.

REFERENCES

1. Love JR, Dubin HV. Xanthomas and lipoproteins. Cutis. 1978; 21: 801- 805.

2. Cruz PD, East C, Bergstresser PR. Dermal, subcutaneous, and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 1988; 19: 95-111.

3. Parker F. Normocholesterolemic xanthomatosis. Arch Dermatol. 1986; 122: 1253-1257.

4. Parker F, Bagdade JD, Odland GF, Bierman EL. Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest. 1970; 49: 2172-2187.

5. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67: 968-977.

6. Smellie WS. Hypertriglyceridaemia in diabetes. BMJ. 2006; 333: 1257- 1260.

7. Wheeler DC, Bernard DB. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis. 1994; 23: 331-346.

8. Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; 39: 169-183.

9. O’Brien T, Dinneen SF, O’Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc. 1993; 68: 860-866.

10. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991; 325: 1196- 1204.

11. Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, Stevenson JC, et al. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol. 1992; 166: 950-955.

12. Kasiske BL, Ma JZ, Kalil RS, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med. 1995; 122: 133-141.

13. Hilbrands LB, Demacker PN, Hoitsma AJ, Stalenhoef AF, Koene RA. The effects of cyclosporine and prednisone on serum lipid and (apo) lipoprotein levels in renal transplant recipients. J Am Soc Nephrol. 1995; 5: 2073-2081.

14. Klor HU, Weizel A, Augustin M, Diepgen TL, Elsner P, Homey B, et al. The impact of oral vitamin A derivatives on lipid metabolism - What recommendations can be derived for dealing with this issue in the daily dermatological practice? J Dtsch Dermatol Ges. 2011; 9: 600-606.

15. Szalat R, Arnulf B, Karlin L, Rybojad M, Asli B, Malphettes M, et al. Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. Blood. 2011; 118: 3777-3784.

16. Patterson JW, Hosler GA, Weedon D. Cutaneous infiltrates - Nonlymphoid. In: Weedon’s Skin Pathology, 4th Edn. Philadelphia. 2015; 1129.

17. Marcoval J, Moreno A, Bordas X, Gallardo F, Peyrí J. Diffuse plane xanthoma: clinicopathologic study of 8 cases. J Am Acad Dermatol. 1998; 39: 439-442.

18. Lee HY, Jin US, Minn KW, Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg. 2013; 40: 380-386.

19. Mourad B, Elgarhy LH, Ellakkawy HA, Elmahdy N. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum. J Cosmet Dermatol. 2015; 14: 209-215.

20. Esmat SM, Elramly AZ, Abdel Halim DM, Gawdat HI, Taha HI. Fractional CO2 laser is an effective therapeutic modality for xanthelasma palpebrarum: a randomized clinical trial. Dermatol Surg. 2014; 40: 1349-1355.

21. Güngör S, Canat D, Gökdemir G. Erbium: YAG laser ablation versus 70% trichloroacet?c acid application in the treatment of xanthelasma palpebrarum. J Dermatolog Treat. 2014; 25: 290-293.

22. Labandeira J, Vázquez-Osorio I, Figueroa-Silva O, Pereiro M, Toribio J. Tolerability and effectiveness of liquid nitrogen spray cryotherapy with very short freeze times in the treatment of xanthelasma palpebrarum. Dermatol Ther. 2015; 28: 346-350.

23. Xanthomas Monograph. 2016.

Vargas-Flores E, Lourdes Estrada-Alpizar E, Arenas-Osuna J (2016) Tuberous Xanthomatosis as a Presentation of Familial Hypercholesterolemia. JSM Clin Case Rep 4(5): 1114.

Received : 17 Aug 2016
Accepted : 27 Sep 2016
Published : 29 Sep 2016
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X